Par, Alkermes Sue Breckenridge To Block Generic Megace
By Kira Lerner ( July 2, 2013, 5:07 PM EDT) -- Par Pharmaceutical Inc. and Alkermes Pharma Ireland Ltd. brought patent infringement allegations in New Jersey federal court Thursday against Breckenridge Pharmaceutical Inc. over the company's plans to make a generic version of the appetite stimulant drug Megace ES....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.